Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
1232
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
1256
1257
1258
1259
1260
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
1289
1290
1291
1292
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
1317
1318
1319
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
1341
1342
1343
1344
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
1355
1356
1357
1358
1359
1360
1361
1362
1363
1364
1365
1366
1367
1368
1369
1370
1371
1372
1373
1374
1375
1376
1377
1378
1379
1380
1381
1382
1383
1384
1385
1386
1387
1388
1389
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
1400
| UnnamedSample_HQ_transcript/81523|m.19956 | UnnamedSample_HQ_transcript/81523 | Coverage 0.766 too low. | 0da7848f97fdf81fac1a1803817db851 | 285 | Pfam | PF01151 | GNS1/SUR4 family | 25 | 262 | 7.3E-60 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/71836|m.18277 | UnnamedSample_HQ_transcript/71836 | Unmapped. | 133c474c2ffc60986ec0d4be332faf93 | 550 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 39 | 192 | 4.7E-14 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/71836|m.18277 | UnnamedSample_HQ_transcript/71836 | Unmapped. | 133c474c2ffc60986ec0d4be332faf93 | 550 | Pfam | PF00183 | Hsp90 protein | 195 | 549 | 6.8E-164 | T | 22-09-2020 | IPR001404 | Heat shock protein Hsp90 family |
| UnnamedSample_HQ_transcript/71573|m.18221 | UnnamedSample_HQ_transcript/71573 | Coverage 0.818 too low. | 874bcc6299a9749f0eca26484cc7315b | 480 | Pfam | PF18004 | 26S proteasome regulatory subunit RPN2 C-terminal domain | 255 | 447 | 1.4E-43 | T | 22-09-2020 | IPR040623 | 26S proteasome regulatory subunit RPN2, C-terminal |
| UnnamedSample_HQ_transcript/71573|m.18221 | UnnamedSample_HQ_transcript/71573 | Coverage 0.818 too low. | 874bcc6299a9749f0eca26484cc7315b | 480 | Pfam | PF13646 | HEAT repeats | 69 | 159 | 3.0E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7589|m.3049 | UnnamedSample_HQ_transcript/7589 | Coverage 0.659 too low. | b236cf40e6874266454f26c67ba1a684 | 1254 | Pfam | PF00595 | PDZ domain | 118 | 178 | 3.2E-10 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/7589|m.3049 | UnnamedSample_HQ_transcript/7589 | Coverage 0.659 too low. | b236cf40e6874266454f26c67ba1a684 | 1254 | Pfam | PF15410 | Pleckstrin homology domain | 653 | 755 | 2.2E-12 | T | 22-09-2020 | IPR041681 | Pleckstrin homology domain 9 |
| UnnamedSample_HQ_transcript/7589|m.3049 | UnnamedSample_HQ_transcript/7589 | Coverage 0.659 too low. | b236cf40e6874266454f26c67ba1a684 | 1254 | Pfam | PF00620 | RhoGAP domain | 873 | 1023 | 4.3E-47 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/54190|m.14872 | UnnamedSample_HQ_transcript/54190 | Coverage 0.173 too low. | e4aa86323015e0ddb8eb3962baffb9aa | 240 | Pfam | PF00069 | Protein kinase domain | 88 | 233 | 5.2E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/84778|m.20457 | UnnamedSample_HQ_transcript/84778 | Coverage 0.753 too low. | 54bd83e3ef075215762664c8b8b2a7b2 | 350 | Pfam | PF00992 | Troponin | 143 | 219 | 4.7E-9 | T | 22-09-2020 | IPR001978 | Troponin |
| UnnamedSample_HQ_transcript/55227|m.15078 | UnnamedSample_HQ_transcript/55227 | Coverage 0.940 too low. | b64391210f8345839e9dcf7a99d697e3 | 522 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 34 | 507 | 2.3E-83 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/62088|m.16465 | UnnamedSample_HQ_transcript/62088 | Coverage 0.220 too low. | f88182392971bcc673e692c974c1a293 | 281 | Pfam | PF16493 | N-terminal of Homeobox Meis and PKNOX1 | 96 | 180 | 2.9E-44 | T | 22-09-2020 | IPR032453 | Homeobox protein PKNOX/Meis, N-terminal |
| UnnamedSample_HQ_transcript/25378|m.8311 | UnnamedSample_HQ_transcript/25378 | Coverage 0.519 too low. | ee35ebfe016896ac77dbf5f5c6738527 | 658 | Pfam | PF02540 | NAD synthase | 224 | 485 | 1.1E-25 | T | 22-09-2020 | IPR022310 | NAD/GMP synthase |
| UnnamedSample_HQ_transcript/25378|m.8311 | UnnamedSample_HQ_transcript/25378 | Coverage 0.519 too low. | ee35ebfe016896ac77dbf5f5c6738527 | 658 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 5 | 166 | 7.6E-15 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/35167|m.10748 | UnnamedSample_HQ_transcript/35167 | Identity 0.770 too low. | aad1cf818dd4335702574da0fd006bf5 | 336 | Pfam | PF13831 | PHD-finger | 253 | 286 | 4.6E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/35167|m.10748 | UnnamedSample_HQ_transcript/35167 | Identity 0.770 too low. | aad1cf818dd4335702574da0fd006bf5 | 336 | Pfam | PF10513 | Enhancer of polycomb-like | 76 | 214 | 2.3E-8 | T | 22-09-2020 | IPR019542 | Enhancer of polycomb-like, N-terminal |
| UnnamedSample_HQ_transcript/35167|m.10748 | UnnamedSample_HQ_transcript/35167 | Identity 0.770 too low. | aad1cf818dd4335702574da0fd006bf5 | 336 | Pfam | PF13832 | PHD-zinc-finger like domain | 292 | 331 | 8.3E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/93861|m.21791 | UnnamedSample_HQ_transcript/93861 | Coverage 0.987 too low. | b30157b9eafd50ddda8838b18e6000ea | 420 | Pfam | PF05303 | Protein of unknown function (DUF727) | 4 | 68 | 6.8E-6 | T | 22-09-2020 | IPR007967 | GSKIP domain |
| UnnamedSample_HQ_transcript/93861|m.21791 | UnnamedSample_HQ_transcript/93861 | Coverage 0.987 too low. | b30157b9eafd50ddda8838b18e6000ea | 420 | Pfam | PF13236 | Clustered mitochondria | 125 | 345 | 1.7E-85 | T | 22-09-2020 | IPR025697 | CLU domain |
| UnnamedSample_HQ_transcript/231|m.200 | UnnamedSample_HQ_transcript/231 | Coverage 0.901 too low. | 3f4bcac5f6404be512d27a6741d5fcb7 | 347 | Pfam | PF00069 | Protein kinase domain | 14 | 272 | 2.1E-76 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/31196|m.9761 | UnnamedSample_HQ_transcript/31196 | Coverage 0.705 too low. | 3f4bcac5f6404be512d27a6741d5fcb7 | 347 | Pfam | PF00069 | Protein kinase domain | 14 | 272 | 2.1E-76 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/55112|m.15061 | UnnamedSample_HQ_transcript/55112 | Coverage 0.229 too low. | 626e1c810ec237d7c343390e598333e6 | 467 | Pfam | PF01285 | TEA/ATTS domain | 65 | 130 | 1.1E-26 | T | 22-09-2020 | IPR000818 | TEA/ATTS domain |
| UnnamedSample_HQ_transcript/55112|m.15061 | UnnamedSample_HQ_transcript/55112 | Coverage 0.229 too low. | 626e1c810ec237d7c343390e598333e6 | 467 | Pfam | PF17725 | YAP binding domain | 255 | 464 | 7.6E-86 | T | 22-09-2020 | IPR041086 | YAP binding domain |
| UnnamedSample_HQ_transcript/93299|m.21712 | UnnamedSample_HQ_transcript/93299 | Coverage 0.753 too low. | 275ce06aa67bcb154ba701b9da25f7f2 | 373 | Pfam | PF09790 | Hyccin | 25 | 353 | 1.4E-96 | T | 22-09-2020 | IPR018619 | Hyccin |
| UnnamedSample_HQ_transcript/96588|m.22176 | UnnamedSample_HQ_transcript/96588 | Coverage 0.523 too low. | 7fc3fd1c2a197cb014a9b8f51eae9c6d | 128 | Pfam | PF08347 | N-terminal CTNNB1 binding | 6 | 75 | 4.8E-7 | T | 22-09-2020 | IPR013558 | CTNNB1 binding, N-teminal |
| UnnamedSample_HQ_transcript/74274|m.18698 | UnnamedSample_HQ_transcript/74274 | Coverage 0.662 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/30580|m.9605 | UnnamedSample_HQ_transcript/30580 | Coverage 0.768 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/59539|m.15963 | UnnamedSample_HQ_transcript/59539 | Coverage 0.578 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/45873|m.13112 | UnnamedSample_HQ_transcript/45873 | Coverage 0.487 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/79341|m.19601 | UnnamedSample_HQ_transcript/79341 | Coverage 0.708 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/39147|m.11676 | UnnamedSample_HQ_transcript/39147 | Coverage 0.460 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/30110|m.9500 | UnnamedSample_HQ_transcript/30110 | Coverage 0.751 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/30893|m.9680 | UnnamedSample_HQ_transcript/30893 | Coverage 0.760 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/31163|m.9752 | UnnamedSample_HQ_transcript/31163 | Coverage 0.743 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/66833|m.17371 | UnnamedSample_HQ_transcript/66833 | Coverage 0.608 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/35869|m.10895 | UnnamedSample_HQ_transcript/35869 | Coverage 0.794 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/69374|m.17824 | UnnamedSample_HQ_transcript/69374 | Coverage 0.627 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/74146|m.18674 | UnnamedSample_HQ_transcript/74146 | Coverage 0.671 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/87303|m.20839 | UnnamedSample_HQ_transcript/87303 | Coverage 0.787 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/57615|m.15570 | UnnamedSample_HQ_transcript/57615 | Coverage 0.547 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/85853|m.20631 | UnnamedSample_HQ_transcript/85853 | Coverage 0.560 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/56606|m.15362 | UnnamedSample_HQ_transcript/56606 | Coverage 0.545 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/54032|m.14839 | UnnamedSample_HQ_transcript/54032 | Coverage 0.554 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/36975|m.11161 | UnnamedSample_HQ_transcript/36975 | Coverage 0.812 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/29303|m.9305 | UnnamedSample_HQ_transcript/29303 | Coverage 0.741 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/36491|m.11048 | UnnamedSample_HQ_transcript/36491 | Coverage 0.822 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/37418|m.11253 | UnnamedSample_HQ_transcript/37418 | Coverage 0.804 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/64574|m.16958 | UnnamedSample_HQ_transcript/64574 | Coverage 0.596 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/22374|m.7537 | UnnamedSample_HQ_transcript/22374 | Coverage 0.680 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/39640|m.11769 | UnnamedSample_HQ_transcript/39640 | Coverage 0.444 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/26729|m.8658 | UnnamedSample_HQ_transcript/26729 | Coverage 0.708 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/27063|m.8730 | UnnamedSample_HQ_transcript/27063 | Coverage 0.701 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/34981|m.10716 | UnnamedSample_HQ_transcript/34981 | Coverage 0.807 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/29653|m.9392 | UnnamedSample_HQ_transcript/29653 | Coverage 0.745 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/33195|m.10253 | UnnamedSample_HQ_transcript/33195 | Coverage 0.768 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/60928|m.16244 | UnnamedSample_HQ_transcript/60928 | Coverage 0.568 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/50726|m.14181 | UnnamedSample_HQ_transcript/50726 | Coverage 0.509 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/52438|m.14533 | UnnamedSample_HQ_transcript/52438 | Coverage 0.518 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/84380|m.20396 | UnnamedSample_HQ_transcript/84380 | Coverage 0.500 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/78107|m.19391 | UnnamedSample_HQ_transcript/78107 | Coverage 0.694 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/59649|m.15989 | UnnamedSample_HQ_transcript/59649 | Coverage 0.581 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/32969|m.10207 | UnnamedSample_HQ_transcript/32969 | Coverage 0.759 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/33685|m.10387 | UnnamedSample_HQ_transcript/33685 | Coverage 0.782 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/83563|m.20274 | UnnamedSample_HQ_transcript/83563 | Coverage 0.573 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/67180|m.17439 | UnnamedSample_HQ_transcript/67180 | Coverage 0.609 too low. | 01325862edc9e5c7f113a74b30c6ef7c | 359 | Pfam | PF00487 | Fatty acid desaturase | 80 | 281 | 9.0E-15 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/121877|m.24985 | UnnamedSample_HQ_transcript/121877 | Coverage 0.962 too low. | 1e73be020f8a99d8d7b11f10c57e541f | 180 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 60 | 99 | 1.9E-24 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/121877|m.24985 | UnnamedSample_HQ_transcript/121877 | Coverage 0.962 too low. | 1e73be020f8a99d8d7b11f10c57e541f | 180 | Pfam | PF00439 | Bromodomain | 1 | 48 | 2.1E-9 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/97989|m.22365 | UnnamedSample_HQ_transcript/97989 | Coverage 0.976 too low. | b02694b38cd095866e43166b77695fae | 343 | Pfam | PF00063 | Myosin head (motor domain) | 89 | 343 | 9.4E-114 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/97989|m.22365 | UnnamedSample_HQ_transcript/97989 | Coverage 0.976 too low. | b02694b38cd095866e43166b77695fae | 343 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 7.7E-15 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/89525|m.21166 | UnnamedSample_HQ_transcript/89525 | Coverage 0.797 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/78297|m.19425 | UnnamedSample_HQ_transcript/78297 | Coverage 0.875 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/85571|m.20582 | UnnamedSample_HQ_transcript/85571 | Coverage 0.863 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/96568|m.22173 | UnnamedSample_HQ_transcript/96568 | Coverage 0.840 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/80641|m.19820 | UnnamedSample_HQ_transcript/80641 | Coverage 0.875 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/85348|m.20554 | UnnamedSample_HQ_transcript/85348 | Coverage 0.866 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/96132|m.22108 | UnnamedSample_HQ_transcript/96132 | Coverage 0.839 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/86754|m.20765 | UnnamedSample_HQ_transcript/86754 | Coverage 0.848 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/78400|m.19444 | UnnamedSample_HQ_transcript/78400 | Coverage 0.838 too low. | 3d7b88d0314bb58c2105b4fc2aa66520 | 320 | Pfam | PF01048 | Phosphorylase superfamily | 81 | 307 | 1.7E-18 | T | 22-09-2020 | IPR000845 | Nucleoside phosphorylase domain |
| UnnamedSample_HQ_transcript/88568|m.21029 | UnnamedSample_HQ_transcript/88568 | Coverage 0.988 too low. | cb3f53162b6f6b0bd431e5f3de772be8 | 214 | Pfam | PF00180 | Isocitrate/isopropylmalate dehydrogenase | 11 | 198 | 7.7E-51 | T | 22-09-2020 | IPR024084 | Isopropylmalate dehydrogenase-like domain |
| UnnamedSample_HQ_transcript/51|m.52 | UnnamedSample_HQ_transcript/51 | Unmapped. | 3e934f79aa6e8b8f13ab835fbaf5e685 | 1633 | Pfam | PF13086 | AAA domain | 445 | 515 | 8.0E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/51|m.52 | UnnamedSample_HQ_transcript/51 | Unmapped. | 3e934f79aa6e8b8f13ab835fbaf5e685 | 1633 | Pfam | PF13087 | AAA domain | 628 | 799 | 1.5E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/26676|m.8643 | UnnamedSample_HQ_transcript/26676 | Identity 0.590 too low. | 20512ac86fd7918731c0dc80411fdecc | 230 | Pfam | PF00685 | Sulfotransferase domain | 23 | 223 | 2.9E-51 | T | 22-09-2020 | IPR000863 | Sulfotransferase domain |
| UnnamedSample_HQ_transcript/18488|m.6444 | UnnamedSample_HQ_transcript/18488 | Unmapped. | 29c051e546daea0f7d88d41bad0c0d35 | 987 | Pfam | PF08762 | CRPV capsid protein like | 673 | 883 | 1.4E-11 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/15848|m.5661 | UnnamedSample_HQ_transcript/15848 | Identity 0.769 too low. | 65178722aaa9ce2eb79d530012d2c63d | 272 | Pfam | PF07084 | Thyroid hormone-inducible hepatic protein Spot 14 | 229 | 268 | 7.1E-6 | T | 22-09-2020 | IPR009786 | Spot 14 family |
| UnnamedSample_HQ_transcript/15848|m.5661 | UnnamedSample_HQ_transcript/15848 | Identity 0.769 too low. | 65178722aaa9ce2eb79d530012d2c63d | 272 | Pfam | PF07084 | Thyroid hormone-inducible hepatic protein Spot 14 | 34 | 138 | 2.2E-12 | T | 22-09-2020 | IPR009786 | Spot 14 family |
| UnnamedSample_HQ_transcript/98957|m.22488 | UnnamedSample_HQ_transcript/98957 | Identity 0.739 too low. | 379be2b092dd35ac7f70c71a1a8e0a41 | 240 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 12 | 219 | 9.5E-44 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/104699|m.23198 | UnnamedSample_HQ_transcript/104699 | Coverage 0.955 too low. | 379be2b092dd35ac7f70c71a1a8e0a41 | 240 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 12 | 219 | 9.5E-44 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/3283|m.1557 | UnnamedSample_HQ_transcript/3283 | Coverage 0.459 too low. | 3c666088d3278cfaaccad16b2471ce21 | 679 | Pfam | PF04434 | SWIM zinc finger | 620 | 647 | 4.7E-5 | T | 22-09-2020 | IPR007527 | Zinc finger, SWIM-type |
| UnnamedSample_HQ_transcript/3283|m.1557 | UnnamedSample_HQ_transcript/3283 | Coverage 0.459 too low. | 3c666088d3278cfaaccad16b2471ce21 | 679 | Pfam | PF15299 | Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 | 61 | 260 | 2.4E-25 | T | 22-09-2020 | IPR029309 | Calcium-responsive transcription factor |
| UnnamedSample_HQ_transcript/3283|m.1557 | UnnamedSample_HQ_transcript/3283 | Coverage 0.459 too low. | 3c666088d3278cfaaccad16b2471ce21 | 679 | Pfam | PF10551 | MULE transposase domain | 326 | 417 | 3.3E-17 | T | 22-09-2020 | IPR018289 | MULE transposase domain |
| UnnamedSample_HQ_transcript/7707|m.3090 | UnnamedSample_HQ_transcript/7707 | Coverage 0.978 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00122 | E1-E2 ATPase | 132 | 325 | 1.8E-51 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7707|m.3090 | UnnamedSample_HQ_transcript/7707 | Coverage 0.978 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 341 | 653 | 1.5E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7707|m.3090 | UnnamedSample_HQ_transcript/7707 | Coverage 0.978 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 724 | 895 | 4.0E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/7707|m.3090 | UnnamedSample_HQ_transcript/7707 | Coverage 0.978 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 28 | 93 | 1.0E-13 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/9868|m.3783 | UnnamedSample_HQ_transcript/9868 | Coverage 0.976 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00122 | E1-E2 ATPase | 132 | 325 | 1.8E-51 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9868|m.3783 | UnnamedSample_HQ_transcript/9868 | Coverage 0.976 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 341 | 653 | 1.5E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9868|m.3783 | UnnamedSample_HQ_transcript/9868 | Coverage 0.976 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 724 | 895 | 4.0E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/9868|m.3783 | UnnamedSample_HQ_transcript/9868 | Coverage 0.976 too low. | 91c2325f5019ac7b6c3257ed4c703ea3 | 912 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 28 | 93 | 1.0E-13 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/17815|m.6248 | UnnamedSample_HQ_transcript/17815 | Identity 0.950 too low. | 07f530fc2063467dfd969dbf9cd7ed1b | 254 | Pfam | PF01044 | Vinculin family | 1 | 199 | 3.3E-50 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/22683|m.7613 | UnnamedSample_HQ_transcript/22683 | Coverage 0.076 too low. | f78440982528fcb0ea3696fbf8a95b7b | 533 | Pfam | PF01403 | Sema domain | 59 | 470 | 1.7E-130 | T | 22-09-2020 | IPR001627 | Sema domain |
| UnnamedSample_HQ_transcript/121715|m.24975 | UnnamedSample_HQ_transcript/121715 | Coverage 0.980 too low. | 81d9ccb11f7b435e1d1695ab17dbafe6 | 155 | Pfam | PF01929 | Ribosomal protein L14 | 46 | 120 | 1.2E-25 | T | 22-09-2020 | IPR002784 | Ribosomal protein L14e domain |
| UnnamedSample_HQ_transcript/121715|m.24975 | UnnamedSample_HQ_transcript/121715 | Coverage 0.980 too low. | 81d9ccb11f7b435e1d1695ab17dbafe6 | 155 | Pfam | PF00467 | KOW motif | 10 | 38 | 2.4E-5 | T | 22-09-2020 | IPR005824 | KOW |
| UnnamedSample_HQ_transcript/81675|m.19978 | UnnamedSample_HQ_transcript/81675 | Identity 0.901 too low. | 260ce75b39099e9c5c3b2b3f093c9568 | 473 | Pfam | PF11838 | ERAP1-like C-terminal domain | 84 | 360 | 2.0E-46 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/4145|m.1861 | UnnamedSample_HQ_transcript/4145 | Coverage 0.831 too low. | db484e722a160a1bed052e392dee2e5f | 1343 | Pfam | PF17908 | APAF-1 helical domain | 470 | 603 | 1.7E-29 | T | 22-09-2020 | IPR041452 | APAF-1 helical domain |
| UnnamedSample_HQ_transcript/4145|m.1861 | UnnamedSample_HQ_transcript/4145 | Coverage 0.831 too low. | db484e722a160a1bed052e392dee2e5f | 1343 | Pfam | PF00400 | WD domain, G-beta repeat | 736 | 773 | 1.6E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/4145|m.1861 | UnnamedSample_HQ_transcript/4145 | Coverage 0.831 too low. | db484e722a160a1bed052e392dee2e5f | 1343 | Pfam | PF00619 | Caspase recruitment domain | 8 | 84 | 3.8E-9 | T | 22-09-2020 | IPR001315 | CARD domain |
| UnnamedSample_HQ_transcript/4145|m.1861 | UnnamedSample_HQ_transcript/4145 | Coverage 0.831 too low. | db484e722a160a1bed052e392dee2e5f | 1343 | Pfam | PF00931 | NB-ARC domain | 126 | 385 | 2.5E-21 | T | 22-09-2020 | IPR002182 | NB-ARC |
| UnnamedSample_HQ_transcript/97652|m.22321 | UnnamedSample_HQ_transcript/97652 | Coverage 0.979 too low. | 0af1a6af78051e62c038ac8c1512ab33 | 118 | Pfam | PF01791 | DeoC/LacD family aldolase | 14 | 100 | 4.9E-11 | T | 22-09-2020 | IPR002915 | DeoC/FbaB/LacD aldolase |
| UnnamedSample_HQ_transcript/117563|m.24644 | UnnamedSample_HQ_transcript/117563 | Coverage 0.925 too low. | f6cda6f732a8b37612b616005864a29c | 177 | Pfam | PF00400 | WD domain, G-beta repeat | 11 | 49 | 3.6E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/117563|m.24644 | UnnamedSample_HQ_transcript/117563 | Coverage 0.925 too low. | f6cda6f732a8b37612b616005864a29c | 177 | Pfam | PF00400 | WD domain, G-beta repeat | 102 | 135 | 3.2E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/117563|m.24644 | UnnamedSample_HQ_transcript/117563 | Coverage 0.925 too low. | f6cda6f732a8b37612b616005864a29c | 177 | Pfam | PF00400 | WD domain, G-beta repeat | 144 | 177 | 2.7E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/117563|m.24644 | UnnamedSample_HQ_transcript/117563 | Coverage 0.925 too low. | f6cda6f732a8b37612b616005864a29c | 177 | Pfam | PF00400 | WD domain, G-beta repeat | 53 | 91 | 2.3E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/93210|m.21698 | UnnamedSample_HQ_transcript/93210 | Coverage 0.989 too low. | 1fcb434477e1413e41d8ab0e6602a183 | 356 | Pfam | PF13639 | Ring finger domain | 4 | 49 | 2.0E-10 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/10026|m.3838 | UnnamedSample_HQ_transcript/10026 | Coverage 0.979 too low. | 52e8681fd8e519c56704ceb35f3e8319 | 163 | Pfam | PF00069 | Protein kinase domain | 1 | 145 | 9.9E-16 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/10477|m.3979 | UnnamedSample_HQ_transcript/10477 | Coverage 0.606 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 560 | 584 | 0.16 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/10477|m.3979 | UnnamedSample_HQ_transcript/10477 | Coverage 0.606 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 462 | 493 | 0.1 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/10477|m.3979 | UnnamedSample_HQ_transcript/10477 | Coverage 0.606 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 590 | 626 | 0.0072 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/10477|m.3979 | UnnamedSample_HQ_transcript/10477 | Coverage 0.606 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 4.6E-70 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/12002|m.4495 | UnnamedSample_HQ_transcript/12002 | Coverage 0.636 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 560 | 584 | 0.16 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/12002|m.4495 | UnnamedSample_HQ_transcript/12002 | Coverage 0.636 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 462 | 493 | 0.1 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/12002|m.4495 | UnnamedSample_HQ_transcript/12002 | Coverage 0.636 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 590 | 626 | 0.0072 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/12002|m.4495 | UnnamedSample_HQ_transcript/12002 | Coverage 0.636 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 4.6E-70 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/21376|m.7244 | UnnamedSample_HQ_transcript/21376 | Coverage 0.757 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 560 | 584 | 0.16 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21376|m.7244 | UnnamedSample_HQ_transcript/21376 | Coverage 0.757 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 462 | 493 | 0.1 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21376|m.7244 | UnnamedSample_HQ_transcript/21376 | Coverage 0.757 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 590 | 626 | 0.0072 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/21376|m.7244 | UnnamedSample_HQ_transcript/21376 | Coverage 0.757 too low. | 4cb3472f0def24d830d9d4efa3ab0cf8 | 752 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 4.6E-70 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/11391|m.4289 | UnnamedSample_HQ_transcript/11391 | Coverage 0.491 too low. | 52a8d41f7aabeeb6acc262216376ed1b | 395 | Pfam | PF00622 | SPRY domain | 216 | 339 | 7.4E-19 | T | 22-09-2020 | IPR003877 | SPRY domain |
| UnnamedSample_HQ_transcript/11391|m.4289 | UnnamedSample_HQ_transcript/11391 | Coverage 0.491 too low. | 52a8d41f7aabeeb6acc262216376ed1b | 395 | Pfam | PF07525 | SOCS box | 352 | 391 | 1.3E-9 | T | 22-09-2020 | IPR001496 | SOCS box domain |
| UnnamedSample_HQ_transcript/66404|m.17293 | UnnamedSample_HQ_transcript/66404 | Coverage 0.974 too low. | 684db4b253864b9a407f777b05a12cfb | 476 | Pfam | PF02931 | Neurotransmitter-gated ion-channel ligand binding domain | 39 | 257 | 7.9E-33 | T | 22-09-2020 | IPR006202 | Neurotransmitter-gated ion-channel ligand-binding domain |
| UnnamedSample_HQ_transcript/66404|m.17293 | UnnamedSample_HQ_transcript/66404 | Coverage 0.974 too low. | 684db4b253864b9a407f777b05a12cfb | 476 | Pfam | PF02932 | Neurotransmitter-gated ion-channel transmembrane region | 266 | 345 | 1.5E-10 | T | 22-09-2020 | IPR006029 | Neurotransmitter-gated ion-channel transmembrane domain |
| UnnamedSample_HQ_transcript/98090|m.22380 | UnnamedSample_HQ_transcript/98090 | Coverage 0.980 too low. | 0ed2d7f355af68c9ca258e2e8044d952 | 315 | Pfam | PF00651 | BTB/POZ domain | 211 | 300 | 2.6E-12 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/22956|m.7678 | UnnamedSample_HQ_transcript/22956 | Coverage 0.853 too low. | 70b9c2ef1616aaf598a857c01f41a169 | 1012 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 6.8E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/22956|m.7678 | UnnamedSample_HQ_transcript/22956 | Coverage 0.853 too low. | 70b9c2ef1616aaf598a857c01f41a169 | 1012 | Pfam | PF17787 | PH domain | 12 | 139 | 1.8E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/22956|m.7678 | UnnamedSample_HQ_transcript/22956 | Coverage 0.853 too low. | 70b9c2ef1616aaf598a857c01f41a169 | 1012 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 1.6E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/22956|m.7678 | UnnamedSample_HQ_transcript/22956 | Coverage 0.853 too low. | 70b9c2ef1616aaf598a857c01f41a169 | 1012 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 6.3E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/10881|m.4107 | UnnamedSample_HQ_transcript/10881 | Identity 0.900 too low. | 1058480a971f94d455a7ebf9e4d61e54 | 288 | Pfam | PF00230 | Major intrinsic protein | 29 | 256 | 6.6E-43 | T | 22-09-2020 | IPR000425 | Major intrinsic protein |
| UnnamedSample_HQ_transcript/41996|m.12260 | UnnamedSample_HQ_transcript/41996 | Coverage 0.922 too low. | 1058480a971f94d455a7ebf9e4d61e54 | 288 | Pfam | PF00230 | Major intrinsic protein | 29 | 256 | 6.6E-43 | T | 22-09-2020 | IPR000425 | Major intrinsic protein |
| UnnamedSample_HQ_transcript/56016|m.15239 | UnnamedSample_HQ_transcript/56016 | Identity 0.708 too low. | 616dbf564bdffe966a51dd66eaa2cd16 | 588 | Pfam | PF17800 | Nucleoplasmin-like domain | 23 | 68 | 2.5E-9 | T | 22-09-2020 | IPR041232 | Nucleoplasmin-like domain |
| UnnamedSample_HQ_transcript/66326|m.17274 | UnnamedSample_HQ_transcript/66326 | Identity 0.679 too low. | 616dbf564bdffe966a51dd66eaa2cd16 | 588 | Pfam | PF17800 | Nucleoplasmin-like domain | 23 | 68 | 2.5E-9 | T | 22-09-2020 | IPR041232 | Nucleoplasmin-like domain |
| UnnamedSample_HQ_transcript/32759|m.10153 | UnnamedSample_HQ_transcript/32759 | Coverage 0.173 too low. | d05ee449e82d4b0d1993242100a10789 | 491 | Pfam | PF00169 | PH domain | 51 | 149 | 4.9E-12 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/32759|m.10153 | UnnamedSample_HQ_transcript/32759 | Coverage 0.173 too low. | d05ee449e82d4b0d1993242100a10789 | 491 | Pfam | PF00169 | PH domain | 334 | 429 | 6.1E-13 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/82416|m.20098 | UnnamedSample_HQ_transcript/82416 | Coverage 0.701 too low. | 98ecc0b1f2c84ba2348b991c8e078090 | 375 | Pfam | PF07690 | Major Facilitator Superfamily | 97 | 281 | 5.3E-24 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/76637|m.19146 | UnnamedSample_HQ_transcript/76637 | Coverage 0.648 too low. | 98ecc0b1f2c84ba2348b991c8e078090 | 375 | Pfam | PF07690 | Major Facilitator Superfamily | 97 | 281 | 5.3E-24 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/88085|m.20952 | UnnamedSample_HQ_transcript/88085 | Coverage 0.736 too low. | 98ecc0b1f2c84ba2348b991c8e078090 | 375 | Pfam | PF07690 | Major Facilitator Superfamily | 97 | 281 | 5.3E-24 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/123879|m.25077 | UnnamedSample_HQ_transcript/123879 | Coverage 0.983 too low. | c153da734c3170bb78c55ca5991e9c34 | 133 | Pfam | PF07052 | Hepatocellular carcinoma-associated antigen 59 | 110 | 133 | 2.7E-5 | T | 22-09-2020 | IPR010756 | Telomere length and silencing protein 1 |
| UnnamedSample_HQ_transcript/6522|m.2714 | UnnamedSample_HQ_transcript/6522 | Coverage 0.737 too low. | 638fab13cc7de13bfc28a4dcaf704ad0 | 287 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 47 | 104 | 2.1E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6522|m.2714 | UnnamedSample_HQ_transcript/6522 | Coverage 0.737 too low. | 638fab13cc7de13bfc28a4dcaf704ad0 | 287 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 92 | 146 | 4.6E-7 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6522|m.2714 | UnnamedSample_HQ_transcript/6522 | Coverage 0.737 too low. | 638fab13cc7de13bfc28a4dcaf704ad0 | 287 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 56 | 113 | 5.6E-10 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6522|m.2714 | UnnamedSample_HQ_transcript/6522 | Coverage 0.737 too low. | 638fab13cc7de13bfc28a4dcaf704ad0 | 287 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 2 | 60 | 2.1E-8 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/6522|m.2714 | UnnamedSample_HQ_transcript/6522 | Coverage 0.737 too low. | 638fab13cc7de13bfc28a4dcaf704ad0 | 287 | Pfam | PF01391 | Collagen triple helix repeat (20 copies) | 154 | 209 | 1.7E-9 | T | 22-09-2020 | IPR008160 | Collagen triple helix repeat |
| UnnamedSample_HQ_transcript/37441|m.11259 | UnnamedSample_HQ_transcript/37441 | Coverage 0.963 too low. | 106fd30702a3168de176d27608c04695 | 684 | Pfam | PF09180 | Prolyl-tRNA synthetase, C-terminal | 600 | 684 | 1.4E-21 | T | 22-09-2020 | IPR016061 | Proline-tRNA ligase, class II, C-terminal |
| UnnamedSample_HQ_transcript/37441|m.11259 | UnnamedSample_HQ_transcript/37441 | Coverage 0.963 too low. | 106fd30702a3168de176d27608c04695 | 684 | Pfam | PF00458 | WHEP-TRS domain | 9 | 58 | 4.6E-16 | T | 22-09-2020 | IPR000738 | WHEP-TRS domain |
| UnnamedSample_HQ_transcript/37441|m.11259 | UnnamedSample_HQ_transcript/37441 | Coverage 0.963 too low. | 106fd30702a3168de176d27608c04695 | 684 | Pfam | PF00458 | WHEP-TRS domain | 85 | 134 | 1.6E-15 | T | 22-09-2020 | IPR000738 | WHEP-TRS domain |
| UnnamedSample_HQ_transcript/37441|m.11259 | UnnamedSample_HQ_transcript/37441 | Coverage 0.963 too low. | 106fd30702a3168de176d27608c04695 | 684 | Pfam | PF03129 | Anticodon binding domain | 473 | 579 | 1.3E-14 | T | 22-09-2020 | IPR004154 | Anticodon-binding |
| UnnamedSample_HQ_transcript/37441|m.11259 | UnnamedSample_HQ_transcript/37441 | Coverage 0.963 too low. | 106fd30702a3168de176d27608c04695 | 684 | Pfam | PF00587 | tRNA synthetase class II core domain (G, H, P, S and T) | 282 | 454 | 1.6E-18 | T | 22-09-2020 | IPR002314 | Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) |
| UnnamedSample_HQ_transcript/35721|m.10864 | UnnamedSample_HQ_transcript/35721 | Identity 0.944 too low. | 080cc8756deda33bbe0a8cfe42e9e531 | 652 | Pfam | PF01363 | FYVE zinc finger | 2 | 49 | 1.5E-13 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/35721|m.10864 | UnnamedSample_HQ_transcript/35721 | Identity 0.944 too low. | 080cc8756deda33bbe0a8cfe42e9e531 | 652 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 220 | 312 | 3.4E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/115933|m.24487 | UnnamedSample_HQ_transcript/115933 | Coverage 0.987 too low. | 1b853235ab3c3dacb293a0deda845117 | 125 | Pfam | PF04034 | Ribosome biogenesis protein, C-terminal | 2 | 86 | 1.7E-35 | T | 22-09-2020 | IPR007177 | 16S/18S rRNA aminocarboxypropyltransferase Tsr3, C-terminal |
| UnnamedSample_HQ_transcript/53309|m.14702 | UnnamedSample_HQ_transcript/53309 | Coverage 0.979 too low. | 460ef407f9fbbe90401e97230836f326 | 525 | Pfam | PF02879 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain II | 205 | 298 | 1.9E-16 | T | 22-09-2020 | IPR005845 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain II |
| UnnamedSample_HQ_transcript/53309|m.14702 | UnnamedSample_HQ_transcript/53309 | Coverage 0.979 too low. | 460ef407f9fbbe90401e97230836f326 | 525 | Pfam | PF02878 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain I | 16 | 156 | 1.1E-35 | T | 22-09-2020 | IPR005844 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain I |
| UnnamedSample_HQ_transcript/53309|m.14702 | UnnamedSample_HQ_transcript/53309 | Coverage 0.979 too low. | 460ef407f9fbbe90401e97230836f326 | 525 | Pfam | PF02880 | Phosphoglucomutase/phosphomannomutase, alpha/beta/alpha domain III | 308 | 421 | 5.8E-29 | T | 22-09-2020 | IPR005846 | Alpha-D-phosphohexomutase, alpha/beta/alpha domain III |
| UnnamedSample_HQ_transcript/82578|m.20128 | UnnamedSample_HQ_transcript/82578 | Coverage 0.964 too low. | 353e354d2c297d1f1ba1e7ae40e8f011 | 339 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 241 | 311 | 1.3E-8 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/82578|m.20128 | UnnamedSample_HQ_transcript/82578 | Coverage 0.964 too low. | 353e354d2c297d1f1ba1e7ae40e8f011 | 339 | Pfam | PF02204 | Vacuolar sorting protein 9 (VPS9) domain | 109 | 212 | 1.0E-22 | T | 22-09-2020 | IPR003123 | VPS9 domain |
| UnnamedSample_HQ_transcript/61500|m.16349 | UnnamedSample_HQ_transcript/61500 | Coverage 0.978 too low. | 56afe1eaa619a7dad4dda660ea643904 | 207 | Pfam | PF00439 | Bromodomain | 70 | 152 | 1.9E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/61500|m.16349 | UnnamedSample_HQ_transcript/61500 | Coverage 0.978 too low. | 56afe1eaa619a7dad4dda660ea643904 | 207 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 164 | 190 | 7.4E-15 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/52246|m.14495 | UnnamedSample_HQ_transcript/52246 | Identity 0.942 too low. | 7ec3322370e49dc791a662c512bbc89b | 643 | Pfam | PF09820 | Predicted AAA-ATPase | 182 | 518 | 6.2E-12 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/19861|m.6827 | UnnamedSample_HQ_transcript/19861 | Identity 0.700 too low. | 162080036a025f17f1f222fec03dae5e | 891 | Pfam | PF00266 | Aminotransferase class-V | 67 | 435 | 2.5E-26 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/7808|m.3124 | UnnamedSample_HQ_transcript/7808 | Coverage 0.188 too low. | b9780f25b74f8b01dd4b2cbb01868608 | 1253 | Pfam | PF06009 | Laminin Domain II | 169 | 291 | 6.9E-10 | T | 22-09-2020 | IPR010307 | Laminin domain II |
| UnnamedSample_HQ_transcript/7808|m.3124 | UnnamedSample_HQ_transcript/7808 | Coverage 0.188 too low. | b9780f25b74f8b01dd4b2cbb01868608 | 1253 | Pfam | PF02210 | Laminin G domain | 527 | 648 | 2.9E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7808|m.3124 | UnnamedSample_HQ_transcript/7808 | Coverage 0.188 too low. | b9780f25b74f8b01dd4b2cbb01868608 | 1253 | Pfam | PF02210 | Laminin G domain | 708 | 827 | 2.9E-12 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7808|m.3124 | UnnamedSample_HQ_transcript/7808 | Coverage 0.188 too low. | b9780f25b74f8b01dd4b2cbb01868608 | 1253 | Pfam | PF02210 | Laminin G domain | 1105 | 1232 | 4.6E-20 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7808|m.3124 | UnnamedSample_HQ_transcript/7808 | Coverage 0.188 too low. | b9780f25b74f8b01dd4b2cbb01868608 | 1253 | Pfam | PF02210 | Laminin G domain | 305 | 459 | 1.5E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/7808|m.3124 | UnnamedSample_HQ_transcript/7808 | Coverage 0.188 too low. | b9780f25b74f8b01dd4b2cbb01868608 | 1253 | Pfam | PF02210 | Laminin G domain | 928 | 1054 | 1.1E-22 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/71631|m.18235 | UnnamedSample_HQ_transcript/71631 | Identity 0.850 too low. | cf1cbced34dc9306ea301e45fbaab9e9 | 458 | Pfam | PF12605 | Casein kinase 1 gamma C terminal | 337 | 440 | 4.5E-16 | T | 22-09-2020 | IPR022247 | Casein kinase 1 gamma C-terminal |
| UnnamedSample_HQ_transcript/71631|m.18235 | UnnamedSample_HQ_transcript/71631 | Identity 0.850 too low. | cf1cbced34dc9306ea301e45fbaab9e9 | 458 | Pfam | PF00069 | Protein kinase domain | 52 | 266 | 7.6E-27 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/36658|m.11084 | UnnamedSample_HQ_transcript/36658 | Identity 0.820 too low. | 82b29492c51b0b0a22205000d488cf50 | 153 | Pfam | PF13869 | Nucleotide hydrolase | 45 | 119 | 9.1E-24 | T | 22-09-2020 | IPR016706 | Cleavage/polyadenylation specificity factor subunit 5 |
| UnnamedSample_HQ_transcript/70503|m.18015 | UnnamedSample_HQ_transcript/70503 | Coverage 0.990 too low. | 3bc921ff051576061eb8f851d013f588 | 505 | Pfam | PF01031 | Dynamin central region | 217 | 503 | 1.6E-104 | T | 22-09-2020 | IPR000375 | Dynamin central domain |
| UnnamedSample_HQ_transcript/70503|m.18015 | UnnamedSample_HQ_transcript/70503 | Coverage 0.990 too low. | 3bc921ff051576061eb8f851d013f588 | 505 | Pfam | PF00350 | Dynamin family | 35 | 207 | 5.2E-53 | T | 22-09-2020 | IPR022812 | Dynamin superfamily |
| UnnamedSample_HQ_transcript/79|m.79 | UnnamedSample_HQ_transcript/79 | Unmapped. | e0b25baf7a051ec9a1b9cd08656472fe | 1604 | Pfam | PF13086 | AAA domain | 252 | 322 | 7.8E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/79|m.79 | UnnamedSample_HQ_transcript/79 | Unmapped. | e0b25baf7a051ec9a1b9cd08656472fe | 1604 | Pfam | PF13087 | AAA domain | 435 | 606 | 1.4E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/59876|m.16034 | UnnamedSample_HQ_transcript/59876 | Identity 0.723 too low. | be9a0961a4b11c5bbd8aa2f743099a9b | 266 | Pfam | PF07719 | Tetratricopeptide repeat | 111 | 142 | 4.6E-5 | T | 22-09-2020 | IPR013105 | Tetratricopeptide repeat 2 |
| UnnamedSample_HQ_transcript/59876|m.16034 | UnnamedSample_HQ_transcript/59876 | Identity 0.723 too low. | be9a0961a4b11c5bbd8aa2f743099a9b | 266 | Pfam | PF00226 | DnaJ domain | 164 | 228 | 2.4E-21 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/47151|m.13401 | UnnamedSample_HQ_transcript/47151 | Identity 0.761 too low. | be9a0961a4b11c5bbd8aa2f743099a9b | 266 | Pfam | PF07719 | Tetratricopeptide repeat | 111 | 142 | 4.6E-5 | T | 22-09-2020 | IPR013105 | Tetratricopeptide repeat 2 |
| UnnamedSample_HQ_transcript/47151|m.13401 | UnnamedSample_HQ_transcript/47151 | Identity 0.761 too low. | be9a0961a4b11c5bbd8aa2f743099a9b | 266 | Pfam | PF00226 | DnaJ domain | 164 | 228 | 2.4E-21 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/53724|m.14788 | UnnamedSample_HQ_transcript/53724 | Identity 0.743 too low. | be9a0961a4b11c5bbd8aa2f743099a9b | 266 | Pfam | PF07719 | Tetratricopeptide repeat | 111 | 142 | 4.6E-5 | T | 22-09-2020 | IPR013105 | Tetratricopeptide repeat 2 |
| UnnamedSample_HQ_transcript/53724|m.14788 | UnnamedSample_HQ_transcript/53724 | Identity 0.743 too low. | be9a0961a4b11c5bbd8aa2f743099a9b | 266 | Pfam | PF00226 | DnaJ domain | 164 | 228 | 2.4E-21 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/55461|m.15123 | UnnamedSample_HQ_transcript/55461 | Coverage 0.977 too low. | 4ea4c4ed51c2155b7087c3bcfd5e824c | 623 | Pfam | PF10588 | NADH-ubiquinone oxidoreductase-G iron-sulfur binding region | 6 | 45 | 5.2E-16 | T | 22-09-2020 | IPR019574 | NADH:ubiquinone oxidoreductase, subunit G, iron-sulphur binding |
| UnnamedSample_HQ_transcript/55461|m.15123 | UnnamedSample_HQ_transcript/55461 | Coverage 0.977 too low. | 4ea4c4ed51c2155b7087c3bcfd5e824c | 623 | Pfam | PF00384 | Molybdopterin oxidoreductase | 198 | 524 | 1.6E-68 | T | 22-09-2020 | IPR006656 | Molybdopterin oxidoreductase |
| UnnamedSample_HQ_transcript/55461|m.15123 | UnnamedSample_HQ_transcript/55461 | Coverage 0.977 too low. | 4ea4c4ed51c2155b7087c3bcfd5e824c | 623 | Pfam | PF09326 | NADH-ubiquinone oxidoreductase subunit G, C-terminal | 555 | 606 | 8.2E-13 | T | 22-09-2020 | IPR015405 | NADH-quinone oxidoreductase, chain G, C-terminal |
| UnnamedSample_HQ_transcript/109065|m.23720 | UnnamedSample_HQ_transcript/109065 | Coverage 0.540 too low. | 227da031db87fc0ce991ca2887c96337 | 147 | Pfam | PF17064 | Sleepless protein | 23 | 122 | 4.0E-6 | T | 22-09-2020 | IPR031424 | Protein quiver |
| UnnamedSample_HQ_transcript/100735|m.22728 | UnnamedSample_HQ_transcript/100735 | Coverage 0.629 too low. | 227da031db87fc0ce991ca2887c96337 | 147 | Pfam | PF17064 | Sleepless protein | 23 | 122 | 4.0E-6 | T | 22-09-2020 | IPR031424 | Protein quiver |
| UnnamedSample_HQ_transcript/116320|m.24518 | UnnamedSample_HQ_transcript/116320 | Coverage 0.450 too low. | 227da031db87fc0ce991ca2887c96337 | 147 | Pfam | PF17064 | Sleepless protein | 23 | 122 | 4.0E-6 | T | 22-09-2020 | IPR031424 | Protein quiver |
| UnnamedSample_HQ_transcript/9833|m.3774 | UnnamedSample_HQ_transcript/9833 | Coverage 0.982 too low. | c59590a8a9ff4915ca94de85fb6bf752 | 1262 | Pfam | PF03165 | MH1 domain | 28 | 129 | 2.1E-19 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/11493|m.4323 | UnnamedSample_HQ_transcript/11493 | Coverage 0.045 too low. | fc568f1f5821cbec476530db3f5c44bd | 1053 | Pfam | PF01074 | Glycosyl hydrolases family 38 N-terminal domain | 124 | 448 | 5.8E-99 | T | 22-09-2020 | IPR000602 | Glycoside hydrolase family 38, N-terminal domain |
| UnnamedSample_HQ_transcript/11493|m.4323 | UnnamedSample_HQ_transcript/11493 | Coverage 0.045 too low. | fc568f1f5821cbec476530db3f5c44bd | 1053 | Pfam | PF07748 | Glycosyl hydrolases family 38 C-terminal domain | 720 | 922 | 1.7E-29 | T | 22-09-2020 | IPR011682 | Glycosyl hydrolase family 38, C-terminal |
| UnnamedSample_HQ_transcript/11493|m.4323 | UnnamedSample_HQ_transcript/11493 | Coverage 0.045 too low. | fc568f1f5821cbec476530db3f5c44bd | 1053 | Pfam | PF09261 | Alpha mannosidase middle domain | 454 | 558 | 5.2E-24 | T | 22-09-2020 | IPR015341 | Glycoside hydrolase family 38, central domain |
| UnnamedSample_HQ_transcript/83437|m.20254 | UnnamedSample_HQ_transcript/83437 | Coverage 0.976 too low. | 5c208e5a401c16256efb4b404f71eb6a | 312 | Pfam | PF00096 | Zinc finger, C2H2 type | 224 | 247 | 2.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/83437|m.20254 | UnnamedSample_HQ_transcript/83437 | Coverage 0.976 too low. | 5c208e5a401c16256efb4b404f71eb6a | 312 | Pfam | PF00096 | Zinc finger, C2H2 type | 196 | 218 | 0.0091 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21023|m.7151 | UnnamedSample_HQ_transcript/21023 | Coverage 0.976 too low. | 5c208e5a401c16256efb4b404f71eb6a | 312 | Pfam | PF00096 | Zinc finger, C2H2 type | 224 | 247 | 2.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/21023|m.7151 | UnnamedSample_HQ_transcript/21023 | Coverage 0.976 too low. | 5c208e5a401c16256efb4b404f71eb6a | 312 | Pfam | PF00096 | Zinc finger, C2H2 type | 196 | 218 | 0.0091 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||